Core Laboratories NV (CLB)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | ||
|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 126,111 | 139,872 | 147,621 | 160,370 |
| Total stockholders’ equity | US$ in thousands | 251,991 | 250,742 | 240,274 | 232,155 |
| Debt-to-capital ratio | 0.33 | 0.36 | 0.38 | 0.41 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $126,111K ÷ ($126,111K + $251,991K)
= 0.33
The debt-to-capital ratio of Core Laboratories NV has been showing a declining trend over the course of the year 2024, decreasing from 0.41 as of March 31 to 0.33 as of December 31. This indicates that the company has been reducing its reliance on debt to finance its operations and investments in relation to its overall capital structure. A lower debt-to-capital ratio generally suggests a stronger financial position and lower financial risk for the company. It appears that Core Laboratories NV has been effectively managing its debt levels and capital structure during the year.
Peer comparison
Dec 31, 2024